Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of flavopiridol in treating patients who have
chronic lymphocytic leukemia that has not responded to treatment with fludarabine. Drugs used
in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or
die